This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
Applied Health Economics and Health Policy Open Access 04 April 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Senior, M. Rollout of high-priced cell and gene therapies forces payer rethink. Nat Biotechnol 36, 291–292 (2018). https://doi.org/10.1038/nbt0418-291a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0418-291a
This article is cited by
-
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
Applied Health Economics and Health Policy (2022)
-
How large pharma impacts biotechnology startup success
Nature Biotechnology (2021)